Chinese biotechnology companies have long copied American drugs for use in their home markets. But one Chinese imitator may now save a novel cancer treatment from oblivion after it was abandoned by its American developer.
Shanghai Sunway Biotech, a biotechnology company in Shanghai, has licensed worldwide rights to the therapy from Onyx Pharmaceuticals, based in Emeryville, Calif., people at both companies said.
